STOCK TITAN

Dexcom Schedules First Quarter 2025 Earnings Release and Conference Call for May 1, 2025 at 4:30 p.m. Eastern Time.

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences earnings

DexCom (NASDAQ:DXCM) has announced its upcoming first quarter 2025 earnings release and conference call schedule. The company will disclose its Q1 2025 financial results after market close on Thursday, May 1, 2025.

Management will host a conference call at 4:30 p.m. Eastern Time on the same day to discuss the quarterly performance. Investors can access the call by dialing (888) 414-4585 (US/Canada) or (646) 960-0331 (International) using confirmation ID '9430114'. A concurrent webcast will be available on the Dexcom investor relations website at investors.dexcom.com, where it will also be archived for future reference.

DexCom (NASDAQ:DXCM) ha annunciato la programmazione della sua prossima comunicazione dei risultati finanziari per il primo trimestre del 2025 e della relativa conferenza telefonica. L'azienda renderà noti i risultati finanziari del Q1 2025 dopo la chiusura del mercato, il giovedì 1 maggio 2025.

La direzione ospiterà una conferenza telefonica alle 16:30 ora orientale dello stesso giorno per discutere le performance trimestrali. Gli investitori possono accedere alla chiamata componendo il numero (888) 414-4585 (US/Canada) o (646) 960-0331 (Internazionale) utilizzando l'ID di conferma '9430114'. Una diretta streaming sarà disponibile sul sito web delle relazioni con gli investitori di Dexcom all'indirizzo investors.dexcom.com, dove sarà anche archiviata per riferimento futuro.

DexCom (NASDAQ:DXCM) ha anunciado su próxima publicación de resultados del primer trimestre de 2025 y la programación de la conferencia telefónica. La compañía revelará sus resultados financieros del Q1 2025 después del cierre del mercado el jueves 1 de mayo de 2025.

La dirección llevará a cabo una conferencia telefónica a las 4:30 p.m. hora del Este el mismo día para discutir el rendimiento trimestral. Los inversores pueden acceder a la llamada marcando (888) 414-4585 (EE. UU./Canadá) o (646) 960-0331 (Internacional) utilizando el ID de confirmación '9430114'. También habrá una transmisión en vivo disponible en el sitio web de relaciones con inversores de Dexcom en investors.dexcom.com, donde también se archivará para referencia futura.

DexCom (NASDAQ:DXCM)은 2025년 1분기 실적 발표 및 컨퍼런스 콜 일정을 발표했습니다. 회사는 2025년 5월 1일 목요일 시장이 마감된 후 Q1 2025 재무 결과를 공개할 예정입니다.

경영진은 같은 날 동부 표준시 오후 4:30에 분기 성과에 대해 논의하기 위한 컨퍼런스 콜을 개최합니다. 투자자들은 (888) 414-4585 (미국/캐나다) 또는 (646) 960-0331 (국제)로 전화하여 확인 ID '9430114'를 사용하여 콜에 참여할 수 있습니다. Dexcom 투자자 관계 웹사이트인 investors.dexcom.com에서 동시 웹캐스트를 이용할 수 있으며, 향후 참조를 위해 아카이브될 것입니다.

DexCom (NASDAQ:DXCM) a annoncé la publication de ses résultats financiers pour le premier trimestre 2025 ainsi que le calendrier de la conférence téléphonique. L'entreprise divulguera ses résultats financiers du Q1 2025 après la fermeture du marché le jeudi 1er mai 2025.

La direction organisera une conférence téléphonique à 16h30, heure de l'Est, le même jour pour discuter de la performance trimestrielle. Les investisseurs peuvent accéder à l'appel en composant le (888) 414-4585 (États-Unis/Canada) ou le (646) 960-0331 (International) en utilisant l'ID de confirmation '9430114'. Un webinaire simultané sera disponible sur le site des relations investisseurs de Dexcom à l'adresse investors.dexcom.com, où il sera également archivé pour référence future.

DexCom (NASDAQ:DXCM) hat die bevorstehende Veröffentlichung der Ergebnisse für das erste Quartal 2025 und den Zeitplan für die Telefonkonferenz angekündigt. Das Unternehmen wird seine finanziellen Ergebnisse für das Q1 2025 nach Börsenschluss am Donnerstag, den 1. Mai 2025 bekannt geben.

Die Geschäftsführung wird am selben Tag um 16:30 Uhr Eastern Time eine Telefonkonferenz abhalten, um die Quartalsleistung zu besprechen. Investoren können an dem Anruf teilnehmen, indem sie (888) 414-4585 (USA/Kanada) oder (646) 960-0331 (International) wählen und die Bestätigungs-ID '9430114' verwenden. Eine gleichzeitige Webübertragung wird auf der Investor-Relations-Website von Dexcom unter investors.dexcom.com verfügbar sein, wo sie auch für zukünftige Referenzen archiviert wird.

Positive
  • None.
Negative
  • None.

SAN DIEGO--(BUSINESS WIRE)-- DexCom, Inc. (NASDAQ:DXCM) today announced that it plans to release its first quarter 2025 financial results after market close on Thursday, May 1, 2025. Management will hold a conference call to review the company's first quarter 2025 performance starting at 4:30 p.m. (Eastern Time) on the same day. The conference call will be concurrently webcast. The link to the webcast will be available on the Dexcom investor relations website at investors.dexcom.com and will be archived there for future reference.

To listen to the conference call, please dial (888) 414-4585 (US/Canada) or (646) 960-0331 (International) and use the confirmation ID "9430114" approximately five minutes prior to the start time.

About DexCom, Inc.

Dexcom empowers people to take control of health through innovative biosensing technology. Founded in 1999, Dexcom has pioneered and set the standard in glucose biosensing for more than 25 years. Its technology has transformed how people manage diabetes and track their glucose, helping them feel more in control and live more confidently.

Category: IR

DexCom, Inc.:

Sean Christensen

Vice President – Finance and Investor Relations

investor-relations@dexcom.com

(858) 200-0200

Source: DexCom, Inc.

FAQ

When will Dexcom (DXCM) release its Q1 2025 earnings?

Dexcom will release its Q1 2025 earnings after market close on Thursday, May 1, 2025.

How can investors join Dexcom's (DXCM) Q1 2025 earnings call?

Investors can dial (888) 414-4585 (US/Canada) or (646) 960-0331 (International) with ID '9430114', or access the webcast at investors.dexcom.com.

What time is Dexcom's (DXCM) Q1 2025 earnings conference call?

The earnings conference call is scheduled for 4:30 p.m. Eastern Time on May 1, 2025.

Where can I find the replay of Dexcom's (DXCM) Q1 2025 earnings call?

The webcast will be archived on Dexcom's investor relations website at investors.dexcom.com for future reference.
Dexcom Inc

NASDAQ:DXCM

DXCM Rankings

DXCM Latest News

DXCM Stock Data

23.64B
390.33M
0.43%
96.56%
2.52%
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States
SAN DIEGO